
|Videos|April 10, 2022
Available Atopic Dermatitis Therapies for Pediatric Patients
Author(s)Miranda Hester
Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, expands on his AD overview from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference is being held from April 9 to 11 in Baltimore, Maryland.
Advertisement
Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, talks the best which medications are best used for mild-to-moderate AD vs moderate-to-severe AD in pediatric patients and more in this video interview.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Journal Digest: September 2, 2026
3
Dermatology Times Launches Derm Nexus Congress for NPs and PAs
4
Addressing Steroid Fear with Non-Steroidal Treatment Options in Psoriasis
5







